Syndicated Research Studies

The world of healthcare is changing rapidly, and tissue diagnostics is becoming one of the most important technologies driving this transformation. From detecting cancer at earlier stages to helping doctors choose personalized treatments, tissue diagnostics is now at the center of precision medicine. As artificial intelligence, digital pathology, and spatial biology continue to evolve, the Tissue Diagnostics Market is experiencing remarkable growth and innovation. Today, hospitals, laboratories, and research centers are increasingly relying on advanced tissue-based testing methods to improve diagnostic accuracy and patient outcomes. This growing demand has also encouraged tissue diagnostic companies to invest heavily in AI-powered pathology tools, multiplex imaging systems, and next-generation biomarker technologies. Why Tissue Diagnostics Is Gaining Global Attention Tissue diagnostics refers to the examination of tissue samples to identify diseases, especially cancer. Traditionally...

Tissue Diagnostics Industry Overview The global tissue diagnostics market size was valued at USD 4.2 billion in 2019 and is expected to register a CAGR of 5.9% over the analysis period. Tissue diagnostics continues to serve as one of the gold standards for cancer diagnosis as these technologies capture the biological context of tumors. With an increasing incidence of cancer, the market for tissue diagnostics has witnessed high demand with lucrative growth opportunities in the near future. A rise in the adoption rate of automated tissue-based diagnostic systems by the research institutes enables them to perform a faster diagnosis of tumors. For instance, in September 2019, West Clinic Cancer Center partnered with F. Hoffmann-La Roche Ltd. to improve patient care by using Roche’s BenchMark ULTRA Automated Advanced Staining System. This system is used for in situ hybridization or immunohistochemical testing to enable faster diagnosis of tumors.  Gather more insight...